Albemarle Corp (ALB.PA) stock
ALB.PANYSEPlastic Materials, Synth Resins & Nonvulcan ElastomersFiscal year ends December 31Also trades as ALB
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3036% below fair value
$43.96+1.77 (+4.20%)
Close on Nov 5, 2026Market cap $11.61BP/E 23.8Yield 1.65%
Albemarle EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Albemarle's EPS for the twelve months ending Sep 30, 2026 was $4.14. For fiscal 2025 it was -$5.76. The highest annual figure on record is $22.84 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.76 | – |
| FY2024 | Dec 31, 2024 | -$11.20 | -183.8% |
| FY2023 | Dec 31, 2023 | $13.36 | -41.5% |
| FY2022 | Dec 31, 2022 | $22.84 | +2054.7% |
| FY2021 | Dec 31, 2021 | $1.06 | -69.9% |
| FY2020 | Dec 31, 2020 | $3.52 | -29.9% |
| FY2019 | Dec 31, 2019 | $5.02 | -20.8% |
| FY2018 | Dec 31, 2018 | $6.34 | +1193.9% |
| FY2017 | Dec 31, 2017 | $0.49 | -91.4% |
| FY2016 | Dec 31, 2016 | $5.68 | +89.3% |
| FY2015 | Dec 31, 2015 | $3.00 | +77.5% |
| FY2014 | Dec 31, 2014 | $1.69 | -65.5% |
| FY2013 | Dec 31, 2013 | $4.90 | +41.2% |
| FY2012 | Dec 31, 2012 | $3.47 | -18.9% |
| FY2011 | Dec 31, 2011 | $4.28 | +24.8% |
| FY2010 | Dec 31, 2010 | $3.43 | +76.8% |
| FY2009 | Dec 31, 2009 | $1.94 | -7.2% |
| FY2008 | Dec 31, 2008 | $2.09 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.15 | – |
| Q2 FY2026 | Jun 30, 2026 | $3.52 | – |
| Q1 FY2026 | Mar 31, 2026 | $2.34 | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.87 | -1434.5% |
| Q3 FY2025 | Sep 30, 2025 | -$1.72 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.16 | – |
| Q1 FY2025 | Mar 31, 2025 | $0.00 | – |
| Q4 FY2024 | Dec 31, 2024 | $0.29 | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.45 | -467.7% |
| Q2 FY2024 | Jun 30, 2024 | -$1.96 | -135.5% |
| Q1 FY2024 | Mar 31, 2024 | -$0.08 | -100.8% |
| Q4 FY2023 | Dec 31, 2023 | -$5.25 | -154.7% |
| Q3 FY2023 | Sep 30, 2023 | $2.57 | -66.2% |
| Q2 FY2023 | Jun 30, 2023 | $5.52 | +59.5% |
| Q1 FY2023 | Mar 31, 2023 | $10.51 | +388.8% |
| Q4 FY2022 | Dec 31, 2022 | $9.60 | – |
| Q3 FY2022 | Sep 30, 2022 | $7.61 | – |
| Q2 FY2022 | Jun 30, 2022 | $3.46 | -4.4% |
| Q1 FY2022 | Mar 31, 2022 | $2.15 | +156.0% |
| Q4 FY2021 | Dec 31, 2021 | -$0.03 | -103.8% |
| Q3 FY2021 | Sep 30, 2021 | -$3.36 | -465.2% |
| Q2 FY2021 | Jun 30, 2021 | $3.62 | +352.5% |
| Q1 FY2021 | Mar 31, 2021 | $0.84 | -16.8% |
| Q4 FY2020 | Dec 31, 2020 | $0.79 | -7.1% |
| Q3 FY2020 | Sep 30, 2020 | $0.92 | -37.0% |
| Q2 FY2020 | Jun 30, 2020 | $0.80 | -44.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.01 | -19.8% |
| Q4 FY2019 | Dec 31, 2019 | $0.85 | -29.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.46 | +21.7% |
| Q2 FY2019 | Jun 30, 2019 | $1.45 | -46.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.26 | +6.8% |
| Q4 FY2018 | Dec 31, 2018 | $1.21 | – |
| Q3 FY2018 | Sep 30, 2018 | $1.20 | +13.2% |
| Q2 FY2018 | Jun 30, 2018 | $2.73 | +196.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.18 | +162.2% |
| Q4 FY2017 | Dec 31, 2017 | -$1.95 | -136.8% |
| Q3 FY2017 | Sep 30, 2017 | $1.06 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.92 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.45 | – |
| Q4 FY2016 | Dec 31, 2016 | $5.30 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?